MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-07-2024
BIOLASE Total Non Current Liabilities 2011-2026 | BIOL
Annual Total Non Current Liabilities BIOLASE
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 5.69 M | 11.5 M | 354 K | 1.86 M | 2.22 M | 1.2 M | 618 K | 804 K | 956 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 11.5 M | 354 K | 2.8 M |
Total Non Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
EDAP TMS S.A.
EDAP
|
7.44 M | $ 4.38 | 1.85 % | $ 164 M |  France |
 |
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B |  USA |
 |
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | USA |
 |
Eargo
EAR
|
161 M | - | - | $ 10.2 M | USA |
 |
Helius Medical Technologies
HSDT
|
252 K | $ 2.29 | - | $ 50.5 M | USA |
 |
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
23.9 M | $ 11.98 | 4.74 % | $ 339 M | USA |
 |
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | USA |
 |
IRIDEX Corporation
IRIX
|
2.33 M | $ 1.0 | -0.99 % | $ 16.9 M | USA |
 |
Alphatec Holdings
ATEC
|
89.9 M | $ 8.09 | -2.18 % | $ 1.21 B | USA |
 |
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | USA |
 |
LivaNova PLC
LIVN
|
516 M | $ 74.45 | 0.84 % | $ 4.06 B |  Britain |
 |
LENSAR
LNSR
|
3.44 M | $ 5.99 | -1.64 % | $ 71.6 M | USA |
 |
Cardiovascular Systems
CSII
|
28.3 M | - | 0.15 % | $ 844 M | USA |
 |
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | USA |
 |
Cytosorbents Corporation
CTSO
|
14 M | $ 0.48 | 4.17 % | $ 29.9 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
116 M | $ 18.39 | 0.11 % | $ 431 M | USA |
 |
MiMedx Group
MDXG
|
65.4 M | $ 3.68 | 1.52 % | $ 544 M | USA |
 |
Delcath Systems
DCTH
|
2.52 M | $ 11.15 | 1.18 % | $ 399 M | USA |
 |
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | USA |
 |
Myomo
MYO
|
275 K | $ 1.05 | 0.48 % | $ 43.9 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Pulmonx Corporation
LUNG
|
25 M | $ 1.52 | -1.94 % | $ 61.8 M | USA |
 |
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | USA |
 |
Orthofix Medical
OFIX
|
83.1 M | $ 10.24 | -4.74 % | $ 406 M |  Curacao |
 |
Neovasc
NVCN
|
9.02 M | - | - | $ 111 M |  Canada |
 |
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
8.87 K | $ 37.9 | -0.84 % | $ 320 M | USA |
 |
Profound Medical Corp.
PROF
|
2.44 M | $ 6.83 | - | $ 206 M | Canada |
 |
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | USA |
 |
Sintx Technologies
SINT
|
1.76 M | $ 2.35 | -1.68 % | $ 6.52 M | USA |
 |
Globus Medical
GMED
|
18.2 M | $ 84.97 | 0.19 % | $ 11.5 B | USA |
 |
Insulet Corporation
PODD
|
1.06 B | $ 154.0 | -0.56 % | $ 10.8 B | USA |
 |
CONMED Corporation
CNMD
|
877 M | $ 37.15 | -0.28 % | $ 1.15 B | USA |
 |
Inspire Medical Systems
INSP
|
24.6 M | $ 42.79 | -2.4 % | $ 1.26 B | USA |
 |
Integer Holdings Corporation
ITGR
|
1.02 B | $ 89.35 | 0.1 % | $ 3.1 B | USA |
 |
Invacare Corporation
IVC
|
325 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.44 B | $ 86.11 | 0.38 % | $ 50.4 B | USA |
 |
TransMedics Group
TMDX
|
34.5 M | $ 70.51 | 2.28 % | $ 2.4 B | USA |